Topical apraclonidine testing of pupillary sympathetic denervation in diabetic patients.
Cakmak
Hasan Basri
HB
D000316:Adrenergic alpha-Agonists; D016477:Artifacts; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis* / Q000503:physiopathology; D003000:Clonidine / Q000031:analogs & derivatives*; D003929:Diabetic Neuropathies / Q000175:diagnosis* / Q000503:physiopathology; D003951:Diagnostic Errors / Q000517:prevention & control; D003941:Diagnostic Techniques, Ophthalmological / Q000592:standards; D006801:Humans; D007498:Iris / Q000294:innervation / Q000503:physiopathology; D008029:Lighting / Q000379:methods; D015588:Observer Variation; D011237:Predictive Value of Tests; D011681:Pupil Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D012025:Reflex, Pupillary / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D017779:Sympathetic Fibers, Postganglionic / Q000187:drug effects / Q000503:physiopathology*
D000316:Adrenergic alpha-Agonists; C016986:apraclonidine; D003000:Clonidine